{
    "doi": "https://doi.org/10.1182/blood.V122.21.1294.1294",
    "article_title": "Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols ",
    "article_date": "November 15, 2013",
    "session_type": "604. Molecular Pharmacology, Drug Resistance: Poster I",
    "abstract_text": "Background and objectives Protocols for acute myeloid leukemia (AML) 1 st line patients are centered on the combination of Cytarabine and an anthracycline; Idarubicin (IDA), Daunorubicin (DNR), or Mitoxantrone (MIT). Patients may be treated with IDA, DNR, or MIT depending on the country of residence, because multiple clinical trials have not found significant differences among them. A new Personalized Medicine (PM) test developed by Vivia Biotech based on pharmacological responses in patient samples (ex vivo) is uncovering individual responses to these treatments. Our objective is to explore whether a significant % of individual patients may respond differently to IDA vs DNR vs MIT treatments, in spite that of their \u201con average\u201d similar response shown by clinical trials. Patients and Methods Multicenter, prospective, non-interventional study of the PETHEMA group for treatment of AML. Bone Marrow (BM) samples were collected at diagnosis for 160 AML patients. Samples were incubated for 48 hours in 96-well plates, each well containing different drugs or drug combinations, each at 8 different concentrations, enabling calculation of dose response curves for each single drug (CYT, IDA, DNR, MIT) and combination used in treatments (CYT-IDA, CYT-DNR, CYT-MIT). Drug response was evaluated as depletion of AML malignant cells in each well after 48 hours incubations. Annexin V-FITC was used to quantify the ability of the drugs to induce apoptosis. Malignant cells were identified with monoclonal antibodies and light scatter properties. 1) We use the whole bone marrow sample, retaining the erythrocyte population and serum proteins, during the entire incubation period; and after 48 h leukocytes are isolated prior to evaluation by flow cytometry. 2) We have pioneered development of a proprietary automated flow cytometry platform called ExviTech. 3) Pharmacological responses are calculated using pharmacokinetic population models. Results Figure left panel shows dose responses for both IDA (red) and DNR (blue) in 125 AML patient samples. Although their average curves (thick red & blue) are similar, the interpatient variability of either drug is quite large. We hypothesized that some patients could show very differential sensitivities to both drugs, as illustrated by the green arrow where a patient sample is resistant to DNR (right shifted dose response curve) but sensitive to IDA (left shifted dose response curve). To identify these cases Figure right panel shows a comparison of the potency IDA vs DNR. Potency is represented by their EC50 (concentration that kills 50% of the cells). Most dots tend to line up, but red dots represent patient samples with a difference in potency between these drugs >30%. Repeating this exercise for IDA-MIT and DNR-MIT to cover all alternatives among the 3 anthracyclines identifies 40% of patients samples with >30% different potency among IDA-DNR-MIT. Repeating this exercise with the combination treatments CYT-IDA, CYT-DNR, CYT-MIT increases to 58% the population of patients whose samples have a differential sensitivity to these anthracyclines. A fraction of this 57% of patients may benefit in if treatment selection among these 3 treatments were to be aided by this ex vivo testing sensitivities. To identify which fraction would benefit we would need a trial specifically designed. Conclusions This preliminary results show that Vivia's PM test seems able to identify a subset of AML patients who's ex vivo pharmacological response to anthracycline drugs is significantly different. Because this ex vivo test accurately predicts the clinical response to CYT-IDA, if these selective anthracycline ex vivo responses translate to clinical responses, a fraction of this 57% subpopulation could benefit significantly from receiving 1 st or 2 nd line treatments based on either IDA, DNR, MIT, and their combinations. Hence this approach stands for European integration of treatment protocols, based on ex vivo individual responses data rather than nationality. Figure 1 View large Download slide Individual different responses to IDA vs DNR in AML Figure 1 View large Download slide Individual different responses to IDA vs DNR in AML  Close modal Disclosures: Primo: Vivia Biotech: Employment. Hernandez-Campo: Vivia Biotech: Employment. Rojas: Vivia Biotech: Employment. Bennett: Vivia Biotech: Employment. Liebana: Vivia Biotech: Employment. Lopez: Vivia Biotech: Employment. Ballesteros: Vivia Biotech: Equity Ownership.",
    "topics": [
        "annexins",
        "anthracycline antibiotics",
        "bone marrow",
        "bone marrow specimen",
        "cytarabine",
        "daunorubicin",
        "drug combinations",
        "drug dosage calculations",
        "equity",
        "erythrocytes"
    ],
    "author_names": [
        "Pau Montesinos",
        "David Martinez",
        "Raimundo Garcia Boyero",
        "Jaime P\u00e9rez de Oteyza",
        "Pascual Fernandez",
        "Josefina Serrano",
        "Angeles Fernandez",
        "Pilar Herrera",
        "Arancha Alonso",
        "Ataulfo Gonzalez",
        "Concepcion Bethancourt",
        "Esperanza Lavilla",
        "Juan Antonio Vera",
        "Bego\u00f1a Navas",
        "Gabriela Rodriguez",
        "Juan Antonio Lopez",
        "Santiago Jimenez Bravo de Laguna",
        "Adriana Simiele",
        "Bernardo Gonzalez",
        "Jose Angel Hernandez Rivas",
        "Raul Cordoba",
        "Consolaci\u00f3n Ray\u00f3n",
        "Carmen Burgaleta",
        "Jordi Sierra",
        "I\u00f1aki Troconiz",
        "Ignacio Ortega",
        "Andrew G. Bosanquet",
        "Daniel Primo",
        "Pilar Hernandez-Campo",
        "Julian Gorrochategui",
        "Jose L. Rojas",
        "Teresa A. Bennett",
        "Belen Liebana",
        "Rocio Lopez",
        "Joan Ballesteros",
        "Federico Moscardo",
        "Miguel Sanz",
        "Joaqu\u00edn Mart\u00ednez"
    ],
    "author_dict_list": [
        {
            "author_name": "Pau Montesinos",
            "author_affiliations": [
                "Hematology, Hospital Universitari i Politecnic La Fe, Valencia, Spain, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "David Martinez",
            "author_affiliations": [
                "Hematology, Hospital Universitari i Politecnic La Fe, Valencia, Spain, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raimundo Garcia Boyero",
            "author_affiliations": [
                "Hematology, Hospital Universitario General de Castellon, Castellon, Spain, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jaime P\u00e9rez de Oteyza",
            "author_affiliations": [
                "Hematology, Hospital de Madrid Norte Sanchinarro, Madrid, Spain, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pascual Fernandez",
            "author_affiliations": [
                "Hematology, Hospital General Universitario de Alicante, Alicante, Spain, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Josefina Serrano",
            "author_affiliations": [
                "Hematology, Hospital Universitario Reina Sofia, Cordoba, Spain, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angeles Fernandez",
            "author_affiliations": [
                "Complejo Hospitalario Xeral Cies de Vigo, Vigo, Spain, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pilar Herrera",
            "author_affiliations": [
                "Hematology, Hospital Universitario Ramon y Cajal, Madrid, Spain, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arancha Alonso",
            "author_affiliations": [
                "Hematology, Hospital Quir\u00f3n, Madrid, Spain"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ataulfo Gonzalez",
            "author_affiliations": [
                "Hematology, Hospital Cl\u00ednico San Carlos, Madrid, Spain, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Concepcion Bethancourt",
            "author_affiliations": [
                "Hematology, Hospital Regional Universitario Carlos Haya, Malaga, Spain, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Esperanza Lavilla",
            "author_affiliations": [
                "Hematology, Hospital Universitario Lucus Augusti, Lugo, Spain, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan Antonio Vera",
            "author_affiliations": [
                "Hematology, Hospital Universitario Virgen Macarena, Sevilla, Spain, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bego\u00f1a Navas",
            "author_affiliations": [
                "Hematology, Hospital Moncloa, Madrid, Spain, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gabriela Rodriguez",
            "author_affiliations": [
                "Hematology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan Antonio Lopez",
            "author_affiliations": [
                "Hematology, Complejo Hospitalario de Ja\u00e9n, Ja\u00e9n, Spain, "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Santiago Jimenez Bravo de Laguna",
            "author_affiliations": [
                "Hospital Universitario de Gran Canaria Doctor Negr\u00edn, Gran Canaria, Spain, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Adriana Simiele",
            "author_affiliations": [
                "Hematology, Hospital Povisa, Vigo, Spain, "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bernardo Gonzalez",
            "author_affiliations": [
                "Hematology, Hospital Universitario de Canarias, Tenerife, Spain, "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Angel Hernandez Rivas",
            "author_affiliations": [
                "Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain, "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raul Cordoba",
            "author_affiliations": [
                "Hematology, Hospital Infanta Sofia, Madrid, Spain, "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Consolaci\u00f3n Ray\u00f3n",
            "author_affiliations": [
                "Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain, "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmen Burgaleta",
            "author_affiliations": [
                "Hematology, Hospital Universitario Principe de Asturias, Madrid, Spain, "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jordi Sierra",
            "author_affiliations": [
                "Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "I\u00f1aki Troconiz",
            "author_affiliations": [
                "Universidad de Navarra, Pamplona, Spain, "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ignacio Ortega",
            "author_affiliations": [
                "Universidad del Pais Vasco, Bilbao, Spain, "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrew G. Bosanquet",
            "author_affiliations": [
                "Bath Cancer Research,, Bath, England, "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel Primo",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pilar Hernandez-Campo",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Julian Gorrochategui",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose L. Rojas",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Teresa A. Bennett",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Belen Liebana",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rocio Lopez",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joan Ballesteros",
            "author_affiliations": [
                "Vivia Biotech, Madrid, Spain, "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Federico Moscardo",
            "author_affiliations": [
                "Hematology, Hospital Universitari i Politecnic La Fe, Valencia, Spain, "
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Miguel Sanz",
            "author_affiliations": [
                "Hematology, Hospital Universitari i Politecnic La Fe, Valencia, Spain, "
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joaqu\u00edn Mart\u00ednez",
            "author_affiliations": [
                "Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-27T15:42:14",
    "is_scraped": "1"
}